Exact Mass: 259.0857914
Exact Mass Matches: 259.0857914
Found 174 metabolites which its exact mass value is equals to given mass value 259.0857914,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Skimmianine
Skimmianine is a furoquinoline alkaloid present mainly in the Rutaceae family, with antispastic, anti-inflammatory activities and antiplatelet aggregation effect. Skimmianine exhibits cytotoxicity against a variety of cancer cell lines and genotoxicity[1]. Skimmianine is a furoquinoline alkaloid present mainly in the Rutaceae family, with antispastic, anti-inflammatory activities and antiplatelet aggregation effect. Skimmianine exhibits cytotoxicity against a variety of cancer cell lines and genotoxicity[1].
Pyrazofurin
C9H13N3O6 (259.08043180000004)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2170 - Orotidylate Decarboxylase Inhibitor D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors
Skimmianine
Skimmianine is an organonitrogen heterocyclic compound, an organic heterotricyclic compound, an oxacycle and an alkaloid antibiotic. Skimmianine is a natural product found in Haplophyllum bucharicum, Haplophyllum cappadocicum, and other organisms with data available. Skimmianine is a furoquinoline alkaloid present mainly in the Rutaceae family, with antispastic, anti-inflammatory activities and antiplatelet aggregation effect. Skimmianine exhibits cytotoxicity against a variety of cancer cell lines and genotoxicity[1]. Skimmianine is a furoquinoline alkaloid present mainly in the Rutaceae family, with antispastic, anti-inflammatory activities and antiplatelet aggregation effect. Skimmianine exhibits cytotoxicity against a variety of cancer cell lines and genotoxicity[1].
Lenalidomide
Lenalidomide (initially known as CC-5013 and marketed as Revlimid by Celgene) is a derivative of thalidomide introduced in 2004. It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic modality, but has also shown efficacy in the hematological disorders known as the myelodysplastic syndromes. [Wikipedia] C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent > C157388 - Immunomodulatory Imide Drug L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D006133 - Growth Substances > D006131 - Growth Inhibitors D007155 - Immunologic Factors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Mizoribine
C9H13N3O6 (259.08043180000004)
Mizoribine belongs to the family of 1-Ribosyl-imidazolecarboxamides. These are organic compounds containing the imidazole ring linked to a ribose ring through a 1-2 bond. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D000893 - Anti-Inflammatory Agents D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors Mizoribine (NSC 289637), an imidazole nucleoside, inhibits HCV RNA replication with IC50 of approximately 100 μM for anti-HCV activity. Immunosuppressant[1]. Mizoribine, an IMPDH inhibitor, inhibits replication of SARS-CoV with IC50s of 3.5 μg/mL and 16 μg/mL for SARS-CoV Frankfurt-1 and SARS-CoV HKU39849, respectively[2]. Mizoribine (NSC 289637), an imidazole nucleoside, inhibits HCV RNA replication with IC50 of approximately 100 μM for anti-HCV activity. Immunosuppressant[1]. Mizoribine, an IMPDH inhibitor, inhibits replication of SARS-CoV with IC50s of 3.5 μg/mL and 16 μg/mL for SARS-CoV Frankfurt-1 and SARS-CoV HKU39849, respectively[2].
BEMORADAN
C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
5-(1H-Indol-3-ylmethyl)-3-methyl-2-thioxo-4-Imidazolidinone
1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxyimidazole-4-carboxamide
C9H13N3O6 (259.08043180000004)
Pyrazofurin
C9H13N3O6 (259.08043180000004)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors
4-Amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxypyrimidin-2-one
C9H13N3O6 (259.08043180000004)
1-(6-Aminopurin-9-yl)-5-methylpyrimidine-2,4-dione
Cyclohexanones
Cyclohexanones, also known as cn-54521-2ci-634tiletamine hydrochloride or cl 399, is a member of the class of compounds known as aralkylamines. Aralkylamines are alkylamines in which the alkyl group is substituted at one carbon atom by an aromatic hydrocarbyl group. Cyclohexanones can be found in tea, which makes cyclohexanones a potential biomarker for the consumption of this food product. Cyclohexanones is the organic compound with the formula (CH2)5CO. The molecule consists of six-carbon cyclic molecule with a ketone functional group. This colorless oil has an odor reminiscent of that of acetone. Over time, samples of cyclohexanone assume a yellow color. Cyclohexanones is slightly soluble in water and miscible with common organic solvents. Billions of kilograms are produced annually, mainly as a precursor to nylon .
Isomaculosidine
Furo(2,3-b)quinolin-4(9H)-one, 6,8-dimethoxy-9-methyl- is a natural product found in Dictamnus albus and Dictamnus dasycarpus with data available.
Pyrazomycin
C9H13N3O6 (259.08043180000004)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors
(-)-alternarlactam|(1S)-6-hydroxy-8-methoxy-1-methyl-1H-cyclopenta[c]isoquinoline-3,5(2H,4H)-dione
4,5,6-Trimethoxyfurl[2,3-b]quinoline|4,5,6-trimethoxyfuroquinoline
4,5,7-trimethoxyfuroquinoline|4,5,7-Trimethoxyfuro[2,3-b]quinoline
Caerulomycin I
A pyridine alkaloid that is 2,2-bipyridine-6-carboxamide substituted by methoxy groups at position 4 and carbamoyl nitrogen respectively. Isolated from the marine-derived actinomycete Actinoalloteichus cyanogriseus, it exhibits antineoplastic activity.
(6E)-3,4-dimethoxy-6-(nitrosomethylidene)-2-pyridin-2-yl-1H-pyridine
5,7-dimethoxy-9-methyl-4,9-dihydrofuro-[2,3-b]-chinolin-4-on|5,7-dimethoxy-9-methyl-9H-furo[2,3-b]quinolin-4-one|Glycarpin|Glycarpine
Skimmianine
Origin: Plant; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids relative retention time with respect to 9-anthracene Carboxylic Acid is 1.053 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.048 Skimmianine is a furoquinoline alkaloid present mainly in the Rutaceae family, with antispastic, anti-inflammatory activities and antiplatelet aggregation effect. Skimmianine exhibits cytotoxicity against a variety of cancer cell lines and genotoxicity[1]. Skimmianine is a furoquinoline alkaloid present mainly in the Rutaceae family, with antispastic, anti-inflammatory activities and antiplatelet aggregation effect. Skimmianine exhibits cytotoxicity against a variety of cancer cell lines and genotoxicity[1].
Lenalidomide
C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent > C157388 - Immunomodulatory Imide Drug L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D006133 - Growth Substances > D006131 - Growth Inhibitors D007155 - Immunologic Factors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
C14H13NO4_4,7,8-Trimethoxyfuro[2,3-b]quinoline
mizoribine
C9H13N3O6 (259.08043180000004)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D000893 - Anti-Inflammatory Agents D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors Mizoribine (NSC 289637), an imidazole nucleoside, inhibits HCV RNA replication with IC50 of approximately 100 μM for anti-HCV activity. Immunosuppressant[1]. Mizoribine, an IMPDH inhibitor, inhibits replication of SARS-CoV with IC50s of 3.5 μg/mL and 16 μg/mL for SARS-CoV Frankfurt-1 and SARS-CoV HKU39849, respectively[2]. Mizoribine (NSC 289637), an imidazole nucleoside, inhibits HCV RNA replication with IC50 of approximately 100 μM for anti-HCV activity. Immunosuppressant[1]. Mizoribine, an IMPDH inhibitor, inhibits replication of SARS-CoV with IC50s of 3.5 μg/mL and 16 μg/mL for SARS-CoV Frankfurt-1 and SARS-CoV HKU39849, respectively[2].
1-Benzyl-4-chloromethylpiperidine hydrochloride
C13H19Cl2N (259.08944740000004)
4-(2-HYDROXY-PHENYL)-4,5,6,7-TETRAHYDRO-1H-IMIDAZO[4,5-C]PYRIDINE-6-CARBOXYLIC ACID
6-Benzyl-4-chloro-5,6,7,8-tetrahydropyrido[4,3-d]pyriMidine
2,3-Dihydro-α-(trifluoromethyl)-1H-indole-2-propanoic acid
ciclobendazole
P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02C - Antinematodal agents > P02CA - Benzimidazole derivatives C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
4-(1-Pyrrolidinyl)-3-(trifluoromethyl)benzoic acid
2-ISOPROPOXY-6-(2,2,2-TRIFLUOROETHOXY)BENZONITRILE
(2S,4R)-4-(2-Fluorobenzyl)pyrrolidine-2-carboxylic acid hydrochloride
(2S,4R)-4-(4-Fluorobenzyl)pyrrolidine-2-carboxylic acid hydrochloride
(S)-2-(2-FLUOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
(R)-2-(2-FLUOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
(S)-2-(3-FLUOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
1-[4-(4-METHYL-4H-PYRAZIN-1-YL)-3-NITRO-PHENYL]-ETHANONE
Fadrozole hydrochloride
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D047072 - Aromatase Inhibitors C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents
2-DIETHOXYMETHYL-THIAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
1,3(2H)-PYRIDINEDICARBOXYLIC ACID, 3-METHYL 1-PHENYL ESTER
Benzenesulfonamide,N,N-bis(2-hydroxyethyl)-4-methyl-
2-amino-1-[4-(2-hydroxy-ethyl)-piperazin-1-yl]-ethanone 2 hcl
Benzenamine,4-[2-(3-chlorophenyl)diazenyl]-N,N-dimethyl-
3-(3-THIOPHEN-2-YL-PYRAZOLO[1,5-A]PYRIMIDIN-6-YL)-PROPAN-1-OL
2-[(2,5-DIMETHYL-FURAN-3-CARBONYL)-AMINO]-BENZOIC ACID
methyl 2-(5-amino-6-oxo-2-phenylpyrimidin-1-yl)acetate
1-Pyrrolidinecarboxylic acid, 4-(acetylthio)-2-(hydroxymethyl)-, 2-propen-1-yl ester, (2S,4S)
(2-AMINO-4-(ISOPROPOXYCARBONYL)PHENYL)BORONIC ACID HYDROCHLORIDE
Cyclopentanecarboxylicacid, 1-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-
1-benzyl-3-(chloromethyl)piperidine
C13H19Cl2N (259.08944740000004)
(R)-2-(3-FLUOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
Methyl 2-amino-4-(3-methoxyphenyl)pyrimidine-5-carboxylate
1-Benzyl-4-(chloromethyl)piperidine hydrochloride
C13H19Cl2N (259.08944740000004)
1H-1,2,4-Triazole-3-carboxylicacid, 1-β-D-ribofuranosyl-, methyl ester
C9H13N3O6 (259.08043180000004)
(S)-2-(4-FLUOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE
Acriflavinium chloride
C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent
(3S,4R)-4-(4-(TRIFLUOROMETHYL)PHENYL)PYRROLIDINE-3-CARBOXYLIC ACID
3-(3-ETHYL-[1,2,4]TRIAZOLO[3,4-B][1,3,4]-THIADIAZOL-6-YL)-2-METHYL-PHENYLAMINE
C12H13N5S (259.08916180000006)
ethyl 8-cyano-7-Methoxy-2-MethyliMidazo[1,2-a]pyridine-3-carboxylate
(4-[(3-METHYL-FURAN-2-CARBONYL)-AMINO]-PHENYL)-ACETIC ACID
trans-4-(2-(Trifluoromethyl)phenyl)pyrrolidine-3-carboxylic acid hydrochloride
imidacloprid d4 (imidazolidin-4,4,5,5 d4)
C9H6ClD4N5O2 (259.07740771199997)
Fosfomycin tromethamine
C254 - Anti-Infective Agent > C255 - Urinary Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents
trans-4-(3-(Trifluoromethyl)phenyl)pyrrolidine-3-carboxylic acid hydrochloride
1H-indole-3-butanoic acid, alpha,gamma-dioxo-, ethyl ester
N(4)-Hydroxycytidine
C9H13N3O6 (259.08043180000004)
A nucleoside analogue that is cytidine which carries a hydroxy group at the N(4)-positon. It has broad-spectrum antiviral activity against influenza, SARS-CoV , SARS-CoV-2 and MERS-CoV. COVID info from DrugBank, Guide to PHARMACOLOGY Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-Fluoro-6-(3-methoxyanilino)purine
C12H10FN5O (259.08693420000003)
3-[(2,5-Dimethyl-furan-3-carbonyl)-amino]-benzoic acid
(3R)-3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
1,1,1-Trifluoro-3-acetamido-4-phenyl butan-2-one(n-acetyl-l-phenylalanyl trifluoromethyl ketone)
Tiletamine Hydrochloride
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002491 - Central Nervous System Agents > D000927 - Anticonvulsants C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
Skimmianin
Skimmianine is a furoquinoline alkaloid present mainly in the Rutaceae family, with antispastic, anti-inflammatory activities and antiplatelet aggregation effect. Skimmianine exhibits cytotoxicity against a variety of cancer cell lines and genotoxicity[1]. Skimmianine is a furoquinoline alkaloid present mainly in the Rutaceae family, with antispastic, anti-inflammatory activities and antiplatelet aggregation effect. Skimmianine exhibits cytotoxicity against a variety of cancer cell lines and genotoxicity[1].
caerulomycin C
A pyridine alkaloid that is 2,2-bipyridine substituted by methoxy groups at positions 3 and 4 and a (E)-(hydroxyimino)methyl group at position 6. Isolated from the marine-derived actinomycete Actinoalloteichus cyanogriseus, it exhibits antineoplastic activity.
(3Z)-2-amino-4-(1H-indol-5-yl)buta-1,3-diene-1,1,3-tricarbonitrile
Propanoic acid [4-[[2-furanyl(oxo)methyl]amino]phenyl] ester
2-[(3-methyl-1-phenyl-1H-pyrazol-4-yl)methylene]-1-hydrazinecarbothioamide
C12H13N5S (259.08916180000006)
Benzoic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester
2-[[(4-Methyl-1-pyrazolyl)-oxomethyl]amino]benzoic acid methyl ester
6-ethyl-5-methyl-2-thiophen-2-yl-1H-pyrazolo[1,5-a]pyrimidin-7-one
Acetic acid [2-(1-acetyl-6-indolyl)-2-oxoethyl] ester
3-Cyano-4,8-bis(methoxymethyl)-1-oxa-2-oxo-1,2-dihydroazulene
2,4-Dimethyl-4,4A-dihydro-1H-(1,3,5)triazino(1,2-A)quinoline-1,3,6(2H,5H)-trione
(10ar)-8,9-dimethoxy-10h,10ah-pyrrolo[1,2-b]isoquinoline-1,5-dione
(1r,2s)-1,2-dihydroxy-1,2-dimethyl-9h-carbazole-3,4-dione
(1s)-5,6-dihydroxy-8-methoxy-1-methyl-1h,2h-cyclopenta[c]isoquinolin-3-one
10-amino-3-hydroxy-7-(3-hydroxypropyl)-2,7-diazatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,5,8(12),9-pentaen-11-one
n-[4-(4-hydroxy-5-methyl-6-oxopyran-2-yl)phenyl]ethanimidic acid
7-(hydroxymethyl)-7-methyl-1h-chromeno[5,6-b]pyrrole-3-carboxylic acid
(3s)-11-hydroxy-3-methoxy-3,7-dimethyl-2-oxa-6-azatricyclo[7.3.1.0⁵,¹³]trideca-1(12),5(13),6,8,10-pentaen-4-one
methyl 6-[(s)-hydroxy(phenyl)methyl]-4-oxo-1h-pyridine-3-carboxylate
n,4-dimethoxy-[2,2'-bipyridine]-6-carboximidic acid
methyl 6-[hydroxy(phenyl)methyl]-4-oxo-1h-pyridine-3-carboxylate
(7s)-7-(hydroxymethyl)-7-methyl-1h-chromeno[5,6-b]pyrrole-3-carboxylic acid
(3z)-3-[amino(hydroxy)methylidene]-5-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2h-pyrazol-4-one
C9H13N3O6 (259.08043180000004)
